Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR

Objective: To investigate the reversal effect of tuberostemonine on MDR in myelogenous leukemia cells K562/ADR. Methods: Human myelogenous leukemia cells K562 and their adriamycin-resistance cells K562/ADR were used. The growth curve of cells treated by tuberostemonine and the Non-toxic concentratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu Jia, Zhao, Huan Dong, Zhu, Cai Feng, Li, Jian, Xie, Hong Juan, Chen, Yu Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436265/
https://www.ncbi.nlm.nih.gov/pubmed/28529625
http://dx.doi.org/10.7150/jca.17688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436265/
https://www.ncbi.nlm.nih.gov/pubmed/28529625
http://dx.doi.org/10.7150/jca.17688

Ejemplares similares